Area of research
Immunology · Rheumatology
Research interest
Research interests include Mast cells and histamine, Eosinophilic Disorders and Syndromes, Asthma and respiratory diseases, and Urticaria and Related Conditions.
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging EWSR1/FUS::NFATC2 Neoplasms of the Bone and Soft Tissue
Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Heterogeneity in PHGDH protein expression potentiates cancer cell dissemination and metastasis
Co-activation of Sonic hedgehog and Wnt signaling in murine retinal precursor cells drives ocular lesions with features of intraocular medulloepithelioma
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis
Tissue ACE phenotyping in lung cancer
Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis
S2k‐Leitlinie: HPV‐assoziierte Läsionen der äußeren Genitalregion und des Anus – Genitalwarzen und Krebsvorstufen der Vulva, des Penis und der peri‐ und intraanalen Haut (Kurzfassung)
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions